📊 QCLS Key Takeaways
Is Q/C Technologies, Inc.. (QCLS) a Good Investment?
Q/C Technologies exhibits severe operational distress with negative gross margins (-52.1%) indicating fundamental business model failure—the company loses money on every unit sold. Operating losses of -$6.1M against minimal revenue of $361.6K combined with negative cash burn of -$5.9M annually creates an unsustainable runway of approximately 12-14 months, while declining revenue (-5.3% YoY) and collapsing shareholder value (ROE -40%) signal deteriorating business fundamentals.
Why Buy Q/C Technologies, Inc.. Stock? QCLS Key Strengths
- Adequate short-term liquidity with current ratio of 1.71x
- No long-term debt providing balance sheet flexibility
- Net income loss improving 14% YoY from severely negative base
QCLS Stock Risks: Q/C Technologies, Inc.. Investment Risks
- Negative gross margin of -52.1% indicates fundamental business model failure (losing money on sales)
- Negative operating cash flow of -$5.9M annually with only ~12-14 months of cash runway at current burn rate
- Revenue declining YoY (-5.3%) with massive operating losses of -$6.1M against $361.6K revenue
- Severe destruction of shareholder value with ROE of -40% and ROA of -15.4%
- Minimal insider activity (1 Form 4 filing in 90 days) suggesting low insider confidence
- Pre-turnaround status with unsustainable cash burn profile
Key Metrics to Watch
- Gross margin trend—must turn positive to indicate viable business model
- Operating cash flow—critical indicator of sustainability with current ~$6M cash position
- Revenue trajectory—reversal of declining trend essential for business viability
- Monthly cash burn rate—determines actual runway before capital raise requirement
- Insider transaction activity—positive signal if management/directors begin buying shares
Q/C Technologies, Inc.. (QCLS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Q/C Technologies, Inc.. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
QCLS Profit Margin, ROE & Profitability Analysis
QCLS vs Healthcare Sector: How Q/C Technologies, Inc.. Compares
How Q/C Technologies, Inc.. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Q/C Technologies, Inc.. Stock Overvalued? QCLS Valuation Analysis 2026
Based on fundamental analysis, Q/C Technologies, Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Q/C Technologies, Inc.. Balance Sheet: QCLS Debt, Cash & Liquidity
QCLS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Q/C Technologies, Inc..'s revenue has declined by 62% over the 5-year period, indicating business contraction. The most recent EPS of $-5.33 indicates the company is currently unprofitable.
QCLS Revenue Growth, EPS Growth & YoY Performance
QCLS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2020 | -$1.9K | -$776.8K | N/A |
| Q1 2020 | $363.5K | -$887.6K | N/A |
| Q3 2019 | $420.8K | -$794.9K | N/A |
| Q2 2019 | $464.5K | -$776.8K | N/A |
| Q1 2019 | $302.5K | -$887.6K | N/A |
| Q3 2018 | $557.1K | -$1.2M | N/A |
| Q2 2018 | $526.6K | -$818.0K | N/A |
| Q1 2018 | $302.5K | -$1.3M | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Q/C Technologies, Inc.. Dividends, Buybacks & Capital Allocation
QCLS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Q/C Technologies, Inc.. (CIK: 0001321834)
📋 Recent SEC Filings
❓ Frequently Asked Questions about QCLS
What is the AI rating for QCLS?
Q/C Technologies, Inc.. (QCLS) has an AI rating of STRONG SELL with 97% confidence, based on fundamental analysis of SEC EDGAR filings.
What are QCLS's key strengths?
Claude: Adequate short-term liquidity with current ratio of 1.71x. No long-term debt providing balance sheet flexibility.
What are the risks of investing in QCLS?
Claude: Negative gross margin of -52.1% indicates fundamental business model failure (losing money on sales). Negative operating cash flow of -$5.9M annually with only ~12-14 months of cash runway at current burn rate.
What is QCLS's revenue and growth?
Q/C Technologies, Inc.. reported revenue of $361.6K.
Does QCLS pay dividends?
Q/C Technologies, Inc.. pays dividends, with $1.4M distributed to shareholders in the trailing twelve months.
Where can I find QCLS SEC filings?
Official SEC filings for Q/C Technologies, Inc.. (CIK: 0001321834) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is QCLS's EPS?
Q/C Technologies, Inc.. has a diluted EPS of $-14.77.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is QCLS a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Q/C Technologies, Inc.. has a STRONG SELL rating with 97% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is QCLS stock overvalued or undervalued?
Valuation metrics for QCLS: ROE of -40.0% (sector avg: 15%), net margin of -1,585.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy QCLS stock in 2026?
Our dual AI analysis gives Q/C Technologies, Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is QCLS's free cash flow?
Q/C Technologies, Inc..'s operating cash flow is $-5.9M, with capital expenditures of $68.2K. FCF margin is -1,640.9%.
How does QCLS compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -1,585.1% (avg: 12%), ROE -40.0% (avg: 15%), current ratio 1.71 (avg: 2).